Advertisement

Central nervous system tumours in adolescents

      Abstract

      Adolescents with brain tumours have been, and in most cases still are, haphazardly assigned, on referral, to either ‘paediatric’ or ‘adult’-based treatment centres. In this age group, there is therefore a history of inconsistent treatment, delivery of inappropriate ‘maturity-related’ care and a reduced chance of gathering vital biological, clinical and treatment-related information germane to this group of patients and their tumours. These days, adolescents with brain tumours should be actively targeted for recruitment into clinical trials and admission into dedicated neuro-oncology centres or programmes that can deliver the necessary and age appropriate multidisciplinary management.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gurney J.G.
        • Smith M.A.
        • Bunin G.R.
        CNS and miscellaneous intracranial and intraspinal neoplasms.
        in: Ries L.A. Smith M.A. Gurney J.G. Linet M. Tamra T. Young J.L. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. NIH Pub. No. 99-4649. National Cancer Institute, Bethesda1999: 46-60
        • Tait D.M.
        • Thornton-Jones H.
        • Bloom H.J.
        • Lemerle J.
        • Morris-Jones P.
        Adjuvant chemotherapy for medulloblastoma.
        Eur. J. Cancer. 1990; 26: 464-469
        • Bailey C.C.
        • Gnekow A.
        • Wellek S.
        • et al.
        Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO).
        Med. Pediatr. Oncol. 1995; 25: 166-178
        • Taylor R.E.
        • Bailey C.C.
        • Robinson K.
        • et al.
        Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma.
        J. Clin. Oncol. 2003; 21: 1581-1591
        • Stiller C.
        Epidemiology of cancer in adolescents.
        Med. Pediatr. Oncol. 2002; 39: 149-155
        • Smith M.A.
        • Gurney J.G.
        • Gloeckler Ries L.A.
        Cancer among adolescents 15–19 years old.
        in: Ries L.A. Smith M.A. Gurney J.G. Linet M. Tamra T. Young J.L. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. NIH Pub. No. 99-4649. National Cancer Institute, Bethesda1999: 157-164
      1. CBTRUS (2002) Statistical Report: Primary Brain Tumors in the United States, 1995–1999. Central Brain Tumor Registry of the United States, 2003.

        • Shochat S.J.
        • Fremgen A.M.
        • Murphy S.B.
        • et al.
        Childhood cancer.
        CA Cancer J. Clin. 2001; 51: 119-130
        • National Statistics
        Cancer Statistics: Registrations. Registrations of Cancer Diagnosed in 1995–1997, England.
        Stationery Office, London2001
        • Zeltzer P.M.
        • Boyett J.M.
        • Finlay J.L.
        • et al.
        Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children.
        J. Clin. Oncol. 1999; 17: 832-845
        • Pollack I.F.
        • Gerszten P.C.
        • Martinez A.J.
        • et al.
        Intracranial ependymomas of childhood.
        Neurosurgery. 1995; 37: 655-666
        • Wisoff J.H.
        • Boyett J.M.
        • Berger M.S.
        • et al.
        Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood.
        J. Neurosurg. 1998; 89: 52-59
        • Albright A.L.
        • Sposto R.
        • Holmes E.
        • et al.
        Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors.
        Neurosurgery. 2000; 47: 879-885
        • Kortmann R.D.
        • Kuhl J.
        • Timmermann B.
        • et al.
        Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood.
        Int. J. Radiat. Oncol. Biol. Phys. 2000; 46: 269-279
        • Gentet J.C.
        • Bouffet E.
        • Doz F.
        • et al.
        Preirradiation chemotherapy including “eight drugs in 1 day” regimen and high-dose methotrexate in childhood medulloblastoma.
        J. Neurosurg . 1995; 82: 608-614
        • Evans A.E.
        • Jenkin R.D.
        • Sposto R.
        • et al.
        The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
        J. Neurosurg. 1990; 72: 572-582
        • Mulhern R.K.
        • Kepner J.L.
        • Thomas P.R.
        • Armstrong F.D.
        • Friedman H.S.
        • Kun L.E.
        Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation.
        J. Clin. Oncol. 1998; 16: 1723-1728
        • Carrie C.
        • Lasset C.
        • Alapetite C.
        • et al.
        Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.
        Cancer. 1994; 74: 2352-2360
        • Greenberg H.S.
        • Chamberlain M.C.
        • Glantz M.J.
        • Wang S.
        Adult medulloblastoma.
        Neuro-oncology. 2001; 3: 29-34
        • Packer R.J.
        • Goldwein J.
        • Nicholson H.S.
        • et al.
        Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy.
        J. Clin. Oncol. 1999; 17: 2127-2136
        • Carrie C.
        • Hoffstetter S.
        • Gomez F.
        • et al.
        Impact of targeting deviations on outcome in medulloblastoma.
        Int. J. Radiat. Oncol. Biol. Phys. 1999; 45: 435-439
        • Moody A.M.
        • Norman A.R.
        • Tait D.
        Paediatric tumours in the adult population.
        Med. Pediatr. Oncol. 1996; 26: 153-159
        • Carrie C.
        • Lasset C.
        • Blay J.Y.
        • et al.
        Medulloblastoma in adults.
        Radiother. Oncol. 1993; 29: 301-307
        • Dhodapkar K.
        • Dunkel I.J.
        • Gardner S.
        • Sapp M.
        • Thoron L.
        • Finlay J.
        Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
        Med. Pediatr. Oncol. 2002; 38: 47-48
        • Finlay J.L.
        • Boyett J.M.
        • Yates A.J.
        • et al.
        Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
        J. Clin. Oncol. 1995; 13: 112-123
        • Pollack I.F.
        • Finkelstein S.D.
        • Burnham J.
        • et al.
        Age and TP53 mutation frequency in childhood malignant gliomas.
        Cancer Res. 2001; 61: 7404-7407
        • Pollack I.F.
        • Finkelstein S.D.
        • Woods J.
        • et al.
        Expression of p53 and prognosis in children with malignant gliomas.
        N. Engl. J. Med. 2002; 346: 420-427
        • Cunningham J.M.
        • Kimmel D.W.
        • Scheithauer B.W.
        • O'Fallon J.R.
        • Novotny P.J.
        • Jenkins R.B.
        Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin.
        J. Neurosurg. 1997; 86: 121-130
        • Bamberg M.
        • Kortmann R.D.
        • Calaminus G.
        • et al.
        Radiation therapy for intracranial germinoma.
        J. Clin. Oncol. 1999; 17: 2585-2592
        • Bouffet E.
        • Baranzelli M.C.
        • Patte C.
        • et al.
        Combined treatment modality for intracranial germinomas.
        Br. J. Cancer. 1999; 79: 1199-1204
        • Calaminus G.
        • Andreussi L.
        • Garre M.L.
        • Kortmann R.D.
        • Schober R.
        • Gobel U.
        Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
        Klin. Padiatr. 1997; 209: 222-227
        • Calaminus G.
        • Nicholson J.C.
        • Alapetite C.
        • et al.
        Malignant CNS germ cell tumors (GCTS).
        Med. Pediatr. Oncol. 2002; 39: 227
        • Merchant T.E.
        • Kiehna E.N.
        • Miles M.A.
        • Zhu J.
        • Xiong X.
        • Mulhern R.K.
        Acute effects of irradiation on cognition.
        Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 1271-1278
        • Lafferty A.R.
        • Chrousos G.P.
        Pituitary tumors in children and adolescents.
        J. Clin. Endocrinol. Metab. 1999; 84: 4317-4323
      2. Rebounders Canada: a non-profit organization that offers support to and networking to adult survivors of childhood cancer and their families: www.rebounders.org, 2003.

      3. On The Tips of The Toes: an organisation promoting outdoor wildlife expeditions and other nature oriented experiences for children and adolescents with cancer, 2003. http://www.cbtrus.org/2002/2002report.pdf.

        • Hargrave D.R.
        • Bouffet E.
        Quality of health information on the internet in paediatric neur-oncology websites.
        Med. Pediatr. Oncol. 2002; 39: 298
      4. Sister Frances Dominica. Douglas House: A ‘respice’ for young people. Eur J Cancer 2003, this issue (doi: 10.1016/j.ejca.2003.08.003).